Ted Rogers Centre for Heart Research logo
  • Follow us on Twitter
  • Follow us on Instagram
  • Follow us on LinkedIn
  • Follow us on Facebook
  • Follow us on YouTube
  • Follow us on Bluesky
Ted Rogers Centre for Heart Research logo
  • About Us
  • Research Awards
  • Education & Training
  • Programs & Initiatives
  • Tools & Resources
  • About Us
    • Our Mission
    • Our Story
    • Our Team
    • Why Heart Failure
    • Careers
    • News
  • Research Funding
    • Education Fund
    • Innovation Fund
  • Education & Training
    • Entrepreneurship for Cardiovascular Health Opportunities (ECHO)
    • ECHO Discovery
    • ECHO PITCH
    • Symposium
    • Trainee Day
    • Events
  • Programs & Initiatives
    • Investigating Heart Failure
      • Translational Biology and Engineering Program (TBEP)
      • Biobanks
    • Personalized Medicine
      • Cardiac Precision Medicine Program
      • Cardiac Genome Clinic
      • Data Science & Machine Learning
      • Cardiotoxicity Prevention
    • Equitable Access to Care
      • Transform HF
      • Digital Health
    • Translating Innovation
      • Translating Innovation
      • Heart Failure Quality & Outcomes
  • Tools & Resources
    • For Patients
      • Heart Hub
      • Get Involved
      • Genetics of the Heart
      • Cancer and the Heart
      • Educational Events
    • For Clinicians
      • Remote Care Tools
      • Measuring Strain
      • PRiMACY Calculator
      • EHMRG Calculator
    • For Researchers
      • Access Biobanks
      • Geneterpret
      • Work With Us
  • Our Mission
  • Our Story
  • Our Team
  • Why Heart Failure
  • Careers
  • News
  • Donate

Latest Stories

New study using stem cells highlights myosin inhibitors as targeted treatment for pediatric hypertrophic cardiomyopathy 

New study using stem cells highlights myosin inhibitors as targeted treatment for pediatric hypertrophic cardiomyopathy 

Apr 19, 2024

Cardiomyopathy is a leading cause of heart failure in children, and there are currently no effective treatments. Could emerging therapies that successfully target the root cause of the condition in adults also work well in children? That was the question Dr....

Exploring the Heart’s Hidden Layers: Advances in Cardiac Fibroblast Diversity

Exploring the Heart’s Hidden Layers: Advances in Cardiac Fibroblast Diversity

Mar 15, 2024

In the realm of cardiac health, an exciting new study has cast light on the intricate details of our hearts, revealing significant differences between the left and right ventricles' fibroblasts. This research, conducted by a team of dedicated scientists from the...

PRIMaCY Risk Calculator Goes Live in EPIC as Part of a First-Time Integration in Canada

PRIMaCY Risk Calculator Goes Live in EPIC as Part of a First-Time Integration in Canada

Jan 24, 2024

For children diagnosed with complex heart conditions like hypertrophic cardiomyopathy (HCM), the diagnosis can be frightening for families and challenging for healthcare providers since the trajectory of the condition is often uncertain. As a leading cause of sudden...

HDAX Therapeutics Announced as Winner of ECHO PITCH 2023

HDAX Therapeutics Announced as Winner of ECHO PITCH 2023

Nov 10, 2023

An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...

Ted Rogers Centre for Heart Research Wins Big at Vascular 2023

Ted Rogers Centre for Heart Research Wins Big at Vascular 2023

Nov 10, 2023

Several members of the Ted Rogers Centre for Heart Research (TRCHR) participated in Vascular 2023, a five-day conference held in Montreal from October 25-29. The conference is a hallmark event organized by several Canadian specialist and research organizations,...

Unlocking another piece of the puzzle: novel approach maps signaling pathways underlying heart failure

Unlocking another piece of the puzzle: novel approach maps signaling pathways underlying heart failure

Jun 6, 2023

Researchers at the Ted Rogers Centre for Heart Research have developed an innovative approach to better understanding the complex signaling mechanisms underlying heart failure. A recent publication in the Proceedings of the National Academy of Sciences (PNAS) offers...

  • Best Cardiovascular Science of the Decade Awards
  • Education Fund
  • Innovation Fund
10th Annual Heart Failure Symposium, October 1, 2025

3D models of heart failure… stiffened hearts in diabetes…. saving infant lives

10th Annual Heart Failure Symposium, October 1, 2025

After a heart attack, this peptide protects the heart from further injury

  • Entrepreneurship for Commercialization of Health Opportunities
  • ECHO Discovery
  • ECHO PITCH 2025
  • Scientific Symposium
  • TRCHR Professional Development Day
  • Events

Featured Event

10th Annual Heart Failure Symposium, October 1, 2025

Heart Failure Symposium 2025

Virtual Library

10th Annual Heart Failure Symposium, October 1, 2025

Visit our YouTube channel filled with world-class heart failure educational sessions on diverse topics

Investigating Heart Failure

  • Translational Biology & Engineering Program (TBEP)
  • Biobanks

Personalized Medicine

  • Cardiac Precision Medicine Program
  • Cardiac Genome Clinic
  • Data Science & Machine Learning
  • Cardiotoxicity Prevention

Equitable Access to Care

  • Transform HF
  • Digital Health
  • Comprehensive Program in Heart Function

Translating Innovation

  • Translating Innovation
  • Heart Failure Quality & Outcomes

For Patients

  • Heart Hub
  • Get Involved
  • Genetics of the Heart
  • Cancer and the Heart
  • Educational Events

For Clinicians

  • Measuring Strain
  • Remote Care Tools
  • PRiMACY Calculator
  • EHMRG Calculator

For Researchers

  • Access Biobanks
  • Geneterpret
  • Work With Us
Protecting mother, fetus in the face of congenital heart disease

Protecting mother, fetus in the face of congenital heart disease

by Ted Rogers Centre for Heart Research | Sep 14, 2017 | Equitable Access to Care, Personalized Medicine, Why Heart Failure

Protecting mother, fetus in the face of congenital heart disease

Cardiac Genome Clinic welcomes new team members

Cardiac Genome Clinic welcomes new team members

by Ted Rogers Centre for Heart Research | Sep 6, 2017 | Investigating Heart Failure, Personalized Medicine

Program is anchored by whole genome sequencing

A new device to fix failing circulation

A new device to fix failing circulation

by Ted Rogers Centre for Heart Research | Jul 18, 2017 | Equitable Access to Care, Funding Opportunities, Investigating Heart Failure, Personalized Medicine, Translating Innovation

Some children are born with just one working ventricle

One heart, two perspectives

One heart, two perspectives

by Ted Rogers Centre for Heart Research | Jul 4, 2017 | Equitable Access to Care, Investigating Heart Failure, Personalized Medicine

Collaborations from lab to clinic, with Dr. Phyllis Billia

First Canadian patient implanted with sensor for heart failure

First Canadian patient implanted with sensor for heart failure

by Ted Rogers Centre for Heart Research | Jun 20, 2017 | Equitable Access to Care, Personalized Medicine, Translating Innovation

New technology funded by Ted Rogers Centre

Advancing health care with data integration technology

Advancing health care with data integration technology

by Ted Rogers Centre for Heart Research | Jun 6, 2017 | Equitable Access to Care, Personalized Medicine, Translating Innovation, Why Heart Failure

The journey to use real-time data for patient care

Beyond the exome

Beyond the exome

by Ted Rogers Centre for Heart Research | May 23, 2017 | Personalized Medicine

Canada’s only cardiac genome clinic searches for HF clues

Canada’s largest meeting on heart failure

Canada’s largest meeting on heart failure

by Ted Rogers Centre for Heart Research | May 13, 2017 | Education & Training, Equitable Access to Care, Events, Investigating Heart Failure, Personalized Medicine

Partnership sparks world-class event

Precision medicine: the path to a cure

Precision medicine: the path to a cure

by Ted Rogers Centre for Heart Research | Mar 30, 2017 | Personalized Medicine, Why Heart Failure

Where decoding the genes of children with HF will lead

How are Ontario heart failure patients being managed?

How are Ontario heart failure patients being managed?

by Ted Rogers Centre for Heart Research | Mar 17, 2017 | Equitable Access to Care, Personalized Medicine, Why Heart Failure

Combing Ontario patient data to find new patterns in heart failure care

« Older Entries
Next Entries »

Recent Stories

  • ECHO Spotlight Series: Yellowbird Diagnostics
  • ECHO Spotlight Series: Quthero Canada
  • Our 2024-25 Innovation Fund Award Winners

Categories

  • Education & Training
  • Equitable Access to Care
  • Events
  • Funding Opportunities
  • Investigating Heart Failure
  • Personalized Medicine
  • Translating Innovation
  • Why Heart Failure
The Promise of a Healthy Heart.
The Promise of a Healthy Heart.

Contact Us

Ted Rogers Centre for Heart Research
661 University Avenue, 14th floor
Toronto, ON    M5G 1M1
communications@tedrogersresearch.ca

Donate

Join Our Mailing List

Thanks! Expect to hear from us soon.

Subscribe

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
TRCHR Partners SickKids UHN UofT

Our Partners

Our Partners

University of Toronto logo
University of Toronto logo
University of Toronto logo
  • © 2025 Ted Rogers Centre for Heart Research
  • Terms of Use